Investigation of Motor Imagery Ability, Body Awareness and Cognitive Functions in Type 2 Diabetes Mellitus

NCT ID: NCT06588894

Last Updated: 2025-08-27

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

100 participants

Study Classification

OBSERVATIONAL

Study Start Date

2024-10-14

Study Completion Date

2025-12-10

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of this study is to examine the relationship between motor imagery skills, body awareness and cognitive functions in individuals with Type 2 Diabetes mellitus.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Motor imagery can be defined as a voluntary action simulation process that involves focusing intently on the cognitive components of motor tasks. In the literature, motor imagery is seen as a window opening to cognitive motor processes and especially motor control. Motor imagery is negatively affected in many diseases that affect the brain and brain functions, such as stroke, Parkinson, and multiple sclerosis, and motor imagery is frequently used in the rehabilitation of these diseases. Poor glycemic control in Type 2 Diabetes mellitus leads to deterioration in brain and cognitive functions. However, no study has been found on the effects of these disorders seen in Type 2 Diabetes mellitus on MI skills. Motor imagery is a mental practice that is becoming widespread in many areas. However, before considering using Motor imagery-based exercises as a therapy tool for patients, it is important to consider the extent to which patients cognitive impairments are related to their ability to form accurate motor images. For example, studies have found that patients with the lack of body awareness may not be able to produce kinesthetic images of motor movements.

Body awareness is the tendency to pay attention to internal bodily sensations and stimuli and includes the cognitive, emotional, and perceptual abilities that constitute the person general self-awareness. Chronic diseases such as Type 2 Diabetes mellitus affect body awareness and image. Body awareness has been found to be associated with clinical parameters related to diabetes, such as fasting blood sugar and HbA1c levels and duration of diabetes in patients with Type 2 Diabetes mellitus. Changes in body awareness may disrupt the patient self-perception, leading to a poor clinical picture and a poor course of chronic diseases. Therefore, it is important to evaluate possible changes in internal body perception.

To our knowledge, no study has been found in the literature examining the relationship between motor imagery skills of individuals with type 2 diabetes mellitus and body awareness and cognitive functions. The existence of this relationship may guide the use of motor imagery as a treatment method in individuals with Type 2 Diabetes mellitus whose body awareness and cognitive functions are impaired.

Individuals who meet the inclusion criteria will be asked to sign an informed consent form. Then, demographic data of the individuals will be collected using a demographic data form. Individuals; motor imagery skills will be assessed using a mental stopwatch and mental rotation, body awareness will be assessed using the Body Awareness Questionnaire, and cognitive functions will be assessed using the Montreal Cognitive Assessment questionnaire.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Type 2 Diabetes Mellitus (T2DM) Cognitive Function Motor İmagery Ability

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Type 2 Diabetes Mellitus

18-65 years old with type 2 DM for at least 5 years

Questionnaire and Physical Exam

Intervention Type BEHAVIORAL

Individuals motor imagery skills will be assessed using a mental chronometer and mental rotation, body awareness will be assessed using the Body Awareness Questionnaire, and cognitive functions will be assessed using the Montreal Cognitive Assessment questionnaire.

Motor Imagery Ability

Intervention Type BEHAVIORAL

Individuals motor imagery skills will be assessed using a mental stopwatch and mental rotation, body awareness will be assessed using the Body Awareness Questionnaire, and cognitive functions will be assessed using theMontreal Cognitive Assessment questionnaire.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Questionnaire and Physical Exam

Individuals motor imagery skills will be assessed using a mental chronometer and mental rotation, body awareness will be assessed using the Body Awareness Questionnaire, and cognitive functions will be assessed using the Montreal Cognitive Assessment questionnaire.

Intervention Type BEHAVIORAL

Motor Imagery Ability

Individuals motor imagery skills will be assessed using a mental stopwatch and mental rotation, body awareness will be assessed using the Body Awareness Questionnaire, and cognitive functions will be assessed using theMontreal Cognitive Assessment questionnaire.

Intervention Type BEHAVIORAL

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Cognitive Function Motor imagery Ability Body Awareness Cognitive Function Body Awareness

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Being a type 2 DM patient between the ages of 18-65 for at least 5 years,
* Being willing to participate in the study,
* Not having any vision, hearing or speech problems that would prevent the tests from being performed.

Exclusion Criteria

* Having previous experience with Motor Imagery techniques or training,
* Having any orthopedic problems that prevent walking,
* Having a history of neurological disease,
* People who are receiving any medication that affects the central nervous system will not be included in the study.
Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Kutahya Health Sciences University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Ismail Okur

Assist. Prof.

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

İsmail Okur, PhD

Role: PRINCIPAL_INVESTIGATOR

Kutahya Health Sciences University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Kutahya Health Sciences University

Kütahya, Central, Turkey (Türkiye)

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

İsmail Okur, Assit. Prof.

Role: CONTACT

+905552436726

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

İsmail Okur, PhD

Role: primary

+905552436726

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2024/03-26

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.